Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Total Debt (2024 - 2025)

Historic Total Debt for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to $9.7 million.

  • Kura Oncology's Total Debt rose 212.2% to $9.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.7 million, marking a year-over-year increase of 212.2%. This contributed to the annual value of $9.5 million for FY2024, which is N/A changed from last year.
  • According to the latest figures from Q3 2025, Kura Oncology's Total Debt is $9.7 million, which was up 212.2% from $9.6 million recorded in Q2 2025.
  • Kura Oncology's Total Debt's 5-year high stood at $9.7 million during Q3 2025, with a 5-year trough of $9.4 million in Q1 2024.